CanSino Biologics Inc (CJH) — Cash Flow Reinvestment Rate

Latest as of December 2021: 0.43x

CanSino Biologics Inc (CJH) has a Cash Flow Reinvestment Rate of 0.43x as of December 2021, reinvesting €344.15 Million (capex €284.07 Million plus investments €-60.09 Million) from operating cash flow of €806.73 Million. Explore capital reinvestment ratio of CanSino Biologics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.43x

(Capex + Investments) / Operating CF

Total Reinvested

€344.15 Million

Capex + Investments

Operating Cash Flow

€806.73 Million

EUR

Capital Expenditures

€284.07 Million

EUR

CanSino Biologics Inc Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for CanSino Biologics Inc across 2 annual periods. Also explore CanSino Biologics Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for CanSino Biologics Inc (2021–2025)

Year-by-year capital reinvestment analysis for CanSino Biologics Inc. For live market cap and broader valuation context, see CanSino Biologics Inc stock valuation.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	10.78x	€839.60 Million	€77.86 Million	€243.90 Million	▲ +748.3%
2021	1.27x	€2.61 Billion	€2.05 Billion	€1.20 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow